Lung Cancer Update cover image

Oncology Today with Dr Neil Love: Management of HER2-Altered Non-Small Cell Lung Cancer?

Lung Cancer Update

00:00

HER2 Mutant - Is There a Receptor on the Cell Surface?

The traditional understanding is the one on the left hand panel. You had lots of HER2 protein on the cell surface, you just need a lot more for the drug to bind and therefore get it. That's the traditional dogma. And in a way, without having too much HER2 protein they kind of just go into the hyperactive where they internalize into the cell and then it gets recycled. So that, if you attach an antibody drug conjugate onto it, it literally just sucks the drug into the cell.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app